Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS

T Kalincik, S Sharman, I Roos, M Freedman, H Atkins, J Burman, J Massey, I Sutton, B Withers, R Macdonell, A Grigg, O Torkildsen, L Bo, A Lehmann, D Horakova, E Havrdova, E Krasulova, M Trneny, T Kozak, A van der Walt Show all